drugset / Trial / NCT02597543

Stress Cardiac MRI for Evaluation of Nonspecific Allograft Dysfunction

NCT02597543

Phase 4 Completed 14 enrolled Paul Kim Astellas Pharma Inc · collab
Non-randomizedParallel-groupSingle-blindDiagnostic

Summary

The investigators will use cardiac MRI to measure the myocardial perfusion reserve and amount of myocardial edema and fibrosis in heart-transplant patients with nonspecific allograft dysfunction in contrast to those with normal graft function. The investigators hypothesize that patients with nonspecific allograft dysfunction will demonstrate decreased myocardial perfusion reserve, related to microvascular allograft vasculopathy, compared to those with normal graft function.

Timeline

Start
2015-11
Primary completion
2016-06-30
Completion
2016-06-30

Publications

Drugs

EvaluationDrugModalityDoseRoute
Background Gadolinium Diagnostic / imaging agent
Background Regadenoson Diagnostic / imaging agent 0.4 mg Intravenous